Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study
伊奈妥单抗联合卡瑞利珠单抗和乌替德隆治疗既往接受过治疗的HER2阳性晚期乳腺癌:一项前瞻性、单臂、II期研究
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-026-04643-z
Lv, Huimin; Sun, Tao; Ling, Xiaoling; Liu, Xinlan; Yang, Jin; Zhang, Mengwei; Niu, Limin; Chen, Shumin; Liu, Zhenzhen; Wang, Chengzheng; Sun, Huihui; Wang, Jing; Zeng, Huiai; Zhao, Shengnan; Guo, Lanwei; Feng, Yajing; Zhang, Zhiqing; Xia, Qingxin; Qiu, Rongguo; Yan, Min